Deutsche Bank Maintains Buy on CVS Health, Lowers Price Target to $95
Deutsche Bank analyst George Hill maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $99 to $95.
CVS Health Leaked Around 1B Search Records By Mistake, Including COVID-19 Vaccine Queries: Forbes
In March, an unsecured database belonging to CVS Health Corp (NYSE: CVS) containing more than 1 billion data points was mistakenly posted online.
‘Fast Money Halftime Report’ Picks For June 15
On CNBC's "Fast Money Halftime Report," Stephanie Link said this is going to be the year when we see the enterprise spending recover and Cisco Systems Inc (NASDAQ: CSCO) stands to benefit
FedEx Rolls Out Nuro Autonomous Delivery Vehicle In Houston
FedEx Corp. (NYSE: FDX) has been testing an autonomous delivery vehicle in the Houston area since April.
CVS Health Shares Quiet; Traders Circulate ‘CVS drug buyers say pharmacy overcharged them $100M as trial opens’
https://medcitynews.com/2021/06/__trashed/
Benzinga’s Bulls And Bears Of The Week: AMC, Apple, Coinbase, CVS, Ford And More
Benzinga has examined the prospects for many investor favorite stocks over the last week.
The week's bullish calls included a Detroit automaker and gold and oil stocks.
The iPhone maker, EV leader and a stock popular with retail traders were among the bearish calls.
Companies, Government Agencies Use Lavish Sweepstakes Prizes To Increase COVID-19 Vaccinations
With less than half of the U.S. population receiving the full dosages of the COVID-19 vaccine, several companies and state governments are still trying to speed the progress of national inoculations by offering extravagant sweepstakes prizes for those who have become fully vaccinated.
Starbucks Is Back!
The so-called "reopening boom" is benefiting Starbucks (NASDAQ: SBUX) along with others from the consumer niche that were hit hard during strict social-distancing limitations over the past year.
Shares Of Pharmacy/Healthcare Stocks Quiet As Traders Circulate Statement From FTC Commissioner Dated Friday That Criticizes Pharmacy Benefits Manager Industry, Is Calling For FTC, Congress To Take Steps To Address Issues In Industry
https://www.ftc.gov/system/files/documents/public_statements/1590528/statement_of_commissioner_rohit_chopra_regarding_the_commissions_report_on_pharmacy_benefit_manager.pdf
‘Fast Money Halftime Report’ Picks For May 27
On CNBC's "Fast Money Halftime Report," Brenda Vingiello said she still likes CVS Health Corp (NYSE: CVS). She sees it as a great play on health care costs coming down over the longer term.